Researchers in Taiwan mapped a 25-microRNA regulatory network driving radioresistance in head and neck cancer and used ...
A new preclinical study reveals that KRAS-mutant gastric adenocarcinoma fosters a TGF-beta-dependent immunosuppressive tumour ...
Lead ADC candidate BYON14156 harnesses company’s first-in-class antifolate payload platform to overcome major payload resistance challenge seen ...
A new review in Medical Oncology argues that simultaneously inducing the iron-driven cell death ferroptosis and the ...
OB-001 is a highly selective and effective inhibitor of two key efflux pumps (P-gp and BCRP), which are present both on the ...
Pharmaceutical Technology on MSN
KymaThera pulls in $80m to bring breast cancer drug to clinic
KymaThera plans to dose the first patients in its Phase I trial on K-1728 in Q4 2026.
A little over a year after landing its flagship approval in chronic hives, Novartis’ oral BTK inhibitor Rhapsido is expanding ...
Heart and kidney complications remain a major concern for people living with type 1 diabetes (T1D). While there are some therapies available to reduce the risk of these complications, the T1D ...
ORIC-259 is a potential first-in-class small molecule mRNA degrader targeting CIP2A, a previously undruggable targetCancer Research UK to fully ...
In this edition of The People’s Pharmacy, Joe and Teresa Graedon also hear from a reader who found that eating an apple helps their heartburn.
That sliminess of mozuku vinegarYou know, mozuku vinegar.The kind sold in three-packs at the supermarket. I often buy it in ...
Standardized patient-derived glioblastoma organoids mirrored patients' radiotherapy responses and showed BET inhibitors may overcome radiation resistance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results